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The associations of physical activity and television (TV) viewing with mortality risk among
individuals with hematologic malignancies remain unclear.

Methods
We examined the relations of physical activity and TV viewing time before and after diagnosis with mortality among 5182 U.S. adults aged 50–71 years from the NIH-AARP Diet and
Health Study cohort who survived a first primary hematologic cancer between 1995–1996
and 2011.

Results
For the pre- and post-diagnosis analyses, we confirmed 2606 and 613 deaths respectively.
In multivariable-adjusted Cox proportional hazard regression models, comparing high (4
hrs/wk) versus low (<1 hr/wk) activity levels, pre-diagnosis physical activity was associated
with 18%-22% reduced risks of all-cause mortality among all hematologic cancer survivors,
and survivors of non-Hodgkin lymphoma, myeloma, and leukemia, respectively. Additional
control for BMI had little impact on the results, expect for myeloma survivors, for whom the
association was no longer significant. Post-diagnosis physical activity was related to risk
reductions in mortality ranging from 36%-47%. The associations for TV viewing did not
show a clear pattern.

Conclusion
Our study suggests that pre- and post-diagnosis physical activity is associated with lower
risk of all-cause mortality among hematologic cancer survivors. Further research is required
to confirm this observation.
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Introduction
Hematologic cancers represent a group of malignant neoplasms of the hematopoietic and lymphoid tissues comprising Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), multiple myeloma, and leukemia. The survival rates for hematologic cancer have increased notably
during the past few decades [1], seemingly as a result of improved diagnosis and health care
services, and population aging. In the USA, 5-year survival rates of HL, NHL, and leukemia
have reached 88%, 71% and 59%, respectively [1].
Cancer patients frequently experience fatigue, depression, and decreased physical function
and quality of life, which are partly the consequences of cancer treatment [2–7]. Moreover,
they are at increased risk of cancer recurrence, second malignancies, other chronic diseases,
and premature death [8–10]. Exercise plays numerous roles to improve health among individuals presenting with cancer [11, 12], yet it remains unclear whether physical activity improves
survival among hematologic cancer patients.
Two randomized controlled studies investigated physical activity in relation to mortality
among 122 lymphoma patients [13] and 103 allogeneic stem cell transplant patients [14], one
of which reported improved survival in the exercise group compared with controls [14],
whereas the other failed to show a statistically significant relation of physical activity to progression-free survival [13]. A recent study [15] prospectively followed 238 cases of diffuse large
B-cell lymphoma (DLBCL) and 175 cases of follicular lymphoma and found a 44% reduction
in mortality among DLBCL survivors who were highly physically active before diagnosis compared with those with low physical activity. However, these studies [13–15] were potentially
limited due to small sample size.
In addition to physical activity, television (TV) viewing time, one of the most prevalent sedentary behaviors, may affect cancer outcomes. The few available observational studies on TV
viewing/leisure sitting time and cancer survival reported conflicting results and were restricted
to cancers of the colorectum [16–18], breast [19], and endometrium [20].
We assembled data from the NIH-AARP Diet and Health Study cohort to examine whether
moderate to vigorous intensity physical activity (MVPA) and TV viewing are related to allcause and cancer-specific mortality risk among individuals diagnosed with hematologic cancer, including HL, NHL, multiple myeloma, and leukemia. We further explored the combined
effects of MVPA and TV viewing time on mortality risk.

Methods
Study population
The NIH-AARP Diet and Health Study is a prospective cohort study of 566,398 adults aged
50–71 years, who completed a mailed baseline questionnaire in 1995–1996 [21]. Individuals
without a history of cancer at baseline who were diagnosed with hematologic cancer between
study entry and 2011 were eligible for this study. Demographic characteristics and medical history were used from the baseline questionnaire. For the pre-diagnosis analysis, physical activity
and TV viewing were collected from the risk factor questionnaire, which was mailed within six
months to those without colon, breast or prostate cancer at baseline (about 60% of the original
cohort) and inquired detailed information about MVPA and time spent watching TV. The follow-up questionnaire sent to participants in 2004–2005 was used to define MVPA and TV
viewing for the post-diagnosis analysis. We excluded participants with missing data on physical activity or TV viewing in the risk factor questionnaire (pre-diagnosis analysis) or follow-up
questionnaire (post-diagnosis analysis), those with missing data on body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) at baseline, those with a
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BMI <18.5 kg/m2 or >65 kg/m2 at baseline, those who died before exposure assessment, and
those who were diagnosed at the date of/after the follow-up questionnaire entry.
The final analytic cohort comprised 5135 hematologic cancer survivors (2585 deaths) for
the pre-diagnosis physical activity and 5182 (2606 deaths) for TV viewing analyses. A total of
1773 individuals (613 deaths) and 1636 individuals (577 deaths) were included to examine the
relations of post-diagnosis physical activity and TV viewing with mortality outcomes. The
NIH–AARP Diet and Health study was approved by the Special Studies Institutional Review
Board of the US National Cancer Institute.

Assessment of physical activity and TV viewing
In the risk factor questionnaire, study members were asked to report how often they participated in leisure time MVPA in the past 10 years: never, rarely, <1, 1 to 3, 4 to 7, or >7 h/wk. A
list of examples of MVPA was provided including tennis, golf (walking), biking, swimming,
heavy gardening, weight lifting, basketball/baseball, football/soccer, cheerleading/drill team,
handball/racquetball, hiking/climbing mountains, fast walking/fast dancing, rowing, aerobics,
jogging/running, and heavy housework. This questionnaire also inquired about hours watching TV or videos per day over the past 12 months: <1, 1 to 2, 3 to 4, 5 to 6, 7 to 8, or 9 h/d.
We collapsed the categories for each exposure into three categories (MVPA: <1, 1 to 3, and
4 h/wk; TV viewing: 0 to 2, 3 to 4, and 5 h/d). In the follow-up questionnaire, participants
were asked to report the weekly time they spent doing MVPA over the prior 12 months, choosing from eight exercise and recreational activities and 10 duration categories ranging from
none to more than 10 h/week for each activity. Participants also reported the hours per day
they spent sitting watching TV, video, or DVD in the previous 12 months, choosing from
eight response categories ranging from 0 to >12 h/d. We created categories for physical activity and TV viewing that are comparable to those of the pre-diagnosis analysis. The risk factor
questionnaire has not been internally validated, but the questions are similar to assessments of
recreational MVPA and TV viewing reported to have reasonable validity [22–25]. The followup questionnaire items showed reasonable correlations with objective measurements of physical activity and sitting time [26].

Ascertainment of hematologic cancer incidence and mortality
We identified hematologic cancer cases through the end of 2011 using linkage to eleven state
cancer registry databases. Hematologic cancer cases, including HL, NHL, myeloma, leukemia
were classified according to the histology codes from the International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) [27]. Leukemia comprised lymphocytic leukemia,
myeloid and monocytic leukemia, and other leukemia. Vital status was identified by annual
linkage of the cohort to the Social Security Administration Death Master File [28] and verified
by the National Death Index (NDI) Plus [29]. We used ICD-9 and ICD-10 codes to classify
mortality from hematologic cancer.

Statistical analysis
Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and
95% confidence intervals (CI) for mortality across different levels of MVPA, TV viewing time,
and the combination of both exposures. We tested for the proportional hazards assumption
using Schoenfeld residuals [30]. For the pre-diagnosis analysis, follow-up was calculated from
the date of cancer diagnosis until either the date of death or December 31, 2011. In the postdiagnosis model, follow-up began on the date of follow-up questionnaire entry.
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The basic model included age at exposure assessment, age at diagnosis, and sex. In a subsequent model, we entered education, race, smoking, alcohol consumption, chemotherapy (first
course of treatment), hematologic cancer subtype, and stage in NHL survivors, and mutually
adjusted for MVPA and TV viewing. The full model additionally included BMI. In supplementary analyses, we additionally adjusted for self-reported health status (baseline questionnaire
for pre-diagnosis analysis and follow-up questionnaire for post-diagnosis analysis).
For trend analyses, we fit a continuous variable assigning each exposure the midpoint of its
respective category. To account for the potential of reverse causation, which could have
occurred if cancer patients had been less physically active due to symptoms of the disease at
the time of physical activity assessment, we performed sensitivity analyses excluding those who
answered the questionnaire within a year of diagnosis. In addition, we excluded individuals
who died within a year of answering pre- and post-diagnosis questionnaires.
We further investigated whether the association of MVPA and TV viewing time with allcause mortality was modified by age at diagnosis, sex, BMI, lag time between exposure assessment and cancer diagnosis, and pre-diagnosis exposures (post-diagnosis analysis). We performed interaction tests using likelihood ratio tests. All analyses were conducted using SAS
version 9.4 (SAS Institute Inc., Cary, NC). P values were considered statistically significant at
the 5% level.

Results
The average times from cancer diagnosis to the end of follow-up and from follow-up questionnaire entry to the end of follow-up were 4.4 and 5.7 years, respectively. Study characteristics of
the included participants are presented in Table 1. Individuals with a low MVPA level and
those with a high level of TV viewing time were more likely to currently smoke than physically
active individuals and those who spent less time watching TV. The physically active survivors
were also more likely to report excellent or very good health. There were no important differences in other study characteristics among the study members.

Physical activity
Compared with engaging in <1 h/wk of MVPA, 4 h/wk of MVPA before diagnosis showed
18% (multivariable-adjusted HR = 0.82, 95% CI = 0.74–0.90), 18% (HR = 0.82, 95% CI = 0.71–
0.95), and 19% (HR = 0.81, 95% CI = 0.69–0.95) reduced risks of all-cause mortality among all
hematologic survivors, NHL survivors, and leukemia survivors, respectively, (Table 2). Among
leukemia survivors, we found a stronger inverse association with pre-diagnosis physical activity for chronic leukemia (HR = 0.65, 95% CI = 0.50–0.83) than acute leukemia (HR = 0.90,
95% CI = 0.72–1.13). We noted an inverse relation of physical activity before diagnosis to mortality risk among myeloma survivors (multivariable-adjusted HR = 0.78, 95% CI = 0.63–0.96),
but that association was no longer statistically significant after additional control for BMI
(HR = 0.81, 95% CI = 0.66–1.01). Among hematologic cancer survivors, we noted an inverse
association of pre- and post-diagnosis MVPA with mortality from hematologic cancer,
although the results for post-diagnosis MVPA did not reach statistical significance in the multivariable-adjusted model (Table 2).
Physical activity performed after diagnosis yielded multivariable-adjusted HRs of all-cause
mortality of 0.61 (95% CI = 0.50–0.74), 0.63 (95% CI = 0.47–0.86), 0.52 (95% CI = 0.31–0.85),
and 0.58 (95% CI = 0.40–0.84) among all hematologic cancer survivors, NHL survivors, myeloma survivors, and leukemia survivors, respectively (Table 2). In a sub-analysis, we restricted
the study population to individuals who provided information on both pre- and post-diagnosis
exposures and noted that the inverse association of post-diagnosis MVPA with mortality
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Table 1. Baseline characteristics of the study participants diagnosed with incident hematologic cancer according to pre-diagnosis physical activity and TV viewing.
Characteristics
Number of participants

Pre-diagnosis physical activity

Pre-diagnosis TV viewing

<1 hr/wk

1 to 3 hrs/wk

4 hrs/week

0 to 2 hrs/d

3 to 4 hrs/d

5 hrs/d

1278

1272

2585

1750

2394

1038

Hematologic cancer subtype, %
Hodgkin lymphoma

1.8

1.9

2.4

2.0

2.0

2.6

Non-Hodgkin lymphoma

49.4

52.9

49.7

53.5

49.4

47.4

Myeloma

16.3

15.7

16.8

16.0

16.3

17.0

Leukemia

32.4

29.5

31.1

28.6

32.2

33.0

Age at exposure assessment, years, mean (SD)

63.5 (5.1)

63.7 (5.0)

64.3 (4.8)

63.3 (5.2)

64.1 (4.8)

64.6 (4.7)

Age at diagnosis, years, mean (SD)

71.0 (6.4)

71.3 (6.4)

72.0 (6.1)

71.1 (6.5)

71.8 (6.2)

71.9 (6.1)

66.9

68.2

69.0

68.6

68.5

66.1

Sex, %
Men
Women
Non-Hispanic White, %

33.1

31.8

31.0

31.4

31.5

33.9

92.8

94.3

94.4

95.2

94.4

90.9

Pre-diagnosis smoking status, %
Never smoker

34.7

35.0

36.7

42.9

32.0

32.2

Past smoker

49.5

52.9

52.5

47.5

54.9

51.9

Current smoker

11.8

9.7

7.8

6.7

10.0

12.3

College graduate/post graduate, %

41.0

43.2

44.3

56.7

39.6

27.4

Pre-diagnosis body mass index, kg/m2, mean (SD)

28.6 (5.3)

27.5 (4.6)

26.6 (3.9)

26.4 (4.0)

27.5 (4.5)

28.6 (5.2)

0 g/d

28.0

21.8

21.4

23.1

22.0

26.0

>0 to 14.9 g/d

54.0

57.7

55.4

55.3

55.5

56.5

15 g/d

18.0

20.6

23.1

21.6

22.5

17.5

28.6

26.7

29.0

29.3

28.0

27.9

Pre-diagnosis alcohol intake, %

Chemotherapy (first course of treatment), %
Pre-diagnosis self-reported heath status, %
Excellent/very good

40.5

49.6

62.2

62.9

52.5

39.8

Good

40.2

39.9

30.0

29.5

36.1

40.9

Fair/poor

17.3

8.9

6.6

6.3

9.8

17.7

All values (except age) are standardized to the age distribution of the study population. Categories may not sum up to 100% due to missing data. Smoking status, body
mass index, alcohol intake, and self-reported health status were assessed in the baseline questionnaire.
https://doi.org/10.1371/journal.pone.0192078.t001

among NHL survivors was attenuated following additional control for pre-diagnosis MVPA
(S1 Table).
Due to low sample size (n = 52), we were not able to explore relations among HL survivors.

TV viewing
Hematologic cancer survivors watching TV 5 hours daily before diagnosis had a 14%
increased risk of all-cause mortality risk compared with those spending 0 to 2 hrs/d watching
TV (multivariable-adjusted HR = 1.14, 95% CI = 1.02–1.28), but the association was no longer
statistically significant following additional control for BMI (HR = 1.10, 95% CI = 0.99–1.24,
Table 3). We noted a statistically significant positive association between pre-diagnosis TV
viewing and mortality among survivors of NHL and acute leukemia.
High vs. low post-diagnosis TV viewing was related to an increased mortality risk among
all leukemia survivors (HR = 1.50, 95% CI = 1.003–2.25) and chronic leukemia survivors
(HR = 1.69, 95% CI = 1.07–2.67, Table 3) in the most comprehensively adjusted model.
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Table 2. HRs and 95% CI of mortality among individuals diagnosed with hematologic cancer according to physical activity before and after diagnosis.
Pre-diagnosis physical activity

Post-diagnosis physical activity

<1 hr/wk

1 to 3 hrs/wk

4 hrs/wk

Person-years

5121

5749

Deaths

701

623

Model 1

1.00

0.81 (0.73–0.90)

0.78 (0.71–0.86)

Model 2

1.00

0.85 (0.76–0.95)

Model 3

1.00

Deaths
Model 1

p-trend

p-trend

<1 hr/wk

1 to <4 hrs/wk

4 hrs/wk

11637

2460

3595

4001

1261

206

216

191

<0.001

1.00

0.72 (0.59–0.87)

0.56 (0.46–0.68)

<0.001

0.82 (0.74–0.90)

<0.001

1.00

0.76 (0.63–0.93)

0.61 (0.50–0.74)

<0.001

0.87 (0.78–0.97)

0.85 (0.77–0.93)

0.005

1.00

0.77 (0.63–0.94)

0.61 (0.50–0.75)

<0.001

485

407

891

95

122

110

1.00

0.77 (0.68–0.88)

0.82 (0.73–0.91)

0.02

1.00

0.87 (0.67–1.14)

0.69 (0.52–0.91)

0.01

Model 2

1.00

0.81 (0.71–0.92)

0.84 (0.75–0.94)

0.03

1.00

0.95 (0.72–1.25)

0.79 (0.59–1.05)

0.08

Model 3

1.00

0.83 (0.72–0.94)

0.87 (0.77–0.97)

0.12

1.00

0.95 (0.72–1.25)

0.79 (0.59–1.06)

0.09

Deaths

295

281

523

85

110

90

Model 1

1.00

0.84 (0.72–0.99)

0.77 (0.67–0.89)

0.001

1.00

0.88 (0.66–1.17)

0.62 (0.46–0.84)

0.001

Model 2

1.00

0.89 (0.75–1.05)

0.82 (0.71–0.95)

0.01

1.00

0.91 (0.68–1.22)

0.63 (0.47–0.86)

0.002

Model 3

1.00

0.90 (0.77–1.07)

0.85 (0.73–0.99)

0.03

1.00

0.93 (0.69–1.24)

0.64 (0.47–0.87)

0.003

Deaths

137

119

274

46

41

34

Model 1

1.00

0.79 (0.62–1.01)

0.86 (0.70–1.05)

0.42

1.00

0.59 (0.39–0.91)

0.47 (0.30–0.75)

0.002

Model 2

1.00

0.75 (0.58–0.96)

0.78 (0.63–0.96)

0.10

1.00

0.65 (0.40–1.05)

0.52 (0.31–0.85)

0.01

Model 3

1.00

0.76 (0.59–0.98)

0.81 (0.66–1.01)

0.24

1.00

0.66 (0.41–1.06)

0.53 (0.32–0.88)

0.02

Deaths

254

211

439

68

61

62

Model 1

1.00

0.82 (0.69–0.99)

0.77 (0.66–0.90)

0.003

1.00

0.63 (0.44–0.89)

0.55 (0.39–0.78)

0.002

Model 2

1.00

0.88 (0.73–1.06)

0.81 (0.69–0.95)

0.01

1.00

0.65 (0.45–0.93)

0.58 (0.40–0.84)

0.01

Model 3

1.00

0.91 (0.75–1.09)

0.84 (0.72–0.99)

0.048

1.00

0.65 (0.45–0.94)

0.56 (0.38–0.83)

0.01

Deaths

134

97

235

Model 1

1.00

0.81 (0.62–1.05)

0.83 (0.67–1.03)

0.20

-

-

-

-

Model 2

1.00

0.76 (0.58–1.01)

0.90 (0.72–1.13)

0.83

-

-

-

-

Model 3

1.00

0.79 (0.60–1.05)

0.94 (0.75–1.18)

0.94

-

-

-

-

All hematologic cancer survivors
All-cause mortality

Hematologic cancer mortality

Non-Hodgkin lymphoma survivors
All-cause mortality

Myeloma survivors
All-cause mortality

Leukemia survivors
All-cause mortality

Acute leukemia survivors
All-cause mortality

Chronic leukemia survivors
All-cause mortality
Deaths

105

100

170

57

49

49

Model 1

1.00

0.91 (0.69–1.20)

0.65 (0.51–0.83)

<0.001

1.00

0.66 (0.45–0.97)

0.54 (0.36–0.79)

0.003

Model 2

1.00

0.92 (0.69–1.22)

0.65 (0.50–0.83)

<0.001

1.00

0.70 (0.47–1.05)

0.57 (0.38–0.86)

0.01

Model 3

1.00

0.93 (0.70–1.24)

0.67 (0.51–0.87)

0.001

1.00

0.68 (0.45–1.03)

0.54 (0.35–0.83)

0.01

HR = hazard ratio, CI = confidence interval. Model 1: adjusted for age at exposure assessment (continuous), age at cancer diagnosis (continuous), and sex. Model 2:
adjusted for all variables in Model 1 and additionally adjusted for education (less than 12 yrs, 12 yrs, vocational training or some college education, college graduate/
postgraduate, unknown), race (non-Hispanic White, non-Hispanic Black, other, unknown), smoking (never smoker, former smoker with 20 cigarettes per day or less,
former smoker with more than 20 cigarettes per day, current smoker with 20 cigarettes per day or less, current smoker with more than 20 cigarettes per day, missing),
alcohol consumption (0, >0 to 14.9, 15g/d), chemotherapy (yes, no, unknown/missing), hematologic cancer subtype (NHL, HL, myeloma, leukemia) and stage in
NHL survivors (localized/regional/in situ, systemic disease, unknown/not abstracted/missing), and TV viewing. Model 3: adjusted for all variables in Model 2 and
additionally adjusted for body mass index (18.5-<25.0kg/m2, 25.0-<30.0 kg/m2, 30.0-<35.kg/m2, 35-<65 kg/m2).


Data were not evaluated for post-diagnosis physical activity due to low sample size (n = 23).

https://doi.org/10.1371/journal.pone.0192078.t002
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Table 3. HRs and 95% CI of mortality among individuals diagnosed with hematologic cancer according to TV viewing before and after diagnosis.
Pre-diagnosis TV viewing
0 to 2 hrs/d

3 to 4 hrs/d

Post-diagnosis TV viewing
5 hrs/d

p-trend

0 to 2 hrs/d

>2 to 4 hrs/d

>4 hrs/d

p-trend

All-cause mortality
Person-years

8127

10223

4426

3560

3439

2240

Deaths

774

1239

593

201

199

177

Model 1

1.00

1.20 (1.10–1.32)

1.30 (1.17–1.45)

<0.001

1.00

1.00 (0.82–1.22)

1.41 (1.15–1.72)

0.003

Model 2

1.00

1.11 (1.01–1.21)

1.14 (1.02–1.28)

0.01

1.00

0.94 (0.77–1.14)

1.20 (0.97–1.48)

0.15

Model 3

1.00

1.09 (0.99–1.19)

1.10 (0.99–1.24)

0.06

1.00

0.93 (0.77–1.14)

1.19 (0.96–1.47)

0.19

Deaths

553

851

391

109

111

86

Model 1

1.00

1.16 (1.04–1.29)

1.21 (1.07–1.38)

0.002

1.00

1.05 (0.80–1.36)

1.29 (0.97–1.72)

0.10

Model 2

1.00

1.08 (0.97–1.21)

1.10 (0.96–1.25)

0.14

1.00

0.99 (0.76–1.30)

1.13 (0.84–1.52)

0.47

Model 3

1.00

1.07 (0.96–1.19)

1.06 (0.93–1.22)

0.32

1.00

0.99 (0.76–1.29)

1.12 (0.83–1.52)

0.51

Deaths

337

524

247

100

96

76

Model 1

1.00

1.27 (1.10–1.45)

1.39 (1.18–1.64)

<0.001

1.00

1.03 (0.78–1.37)

1.30 (0.96–1.75)

0.12

Model 2

1.00

1.18 (1.02–1.36)

1.25 (1.05–1.49)

0.01

1.00

1.04 (0.78–1.38)

1.17 (0.86–1.60)

0.34

Model 3

1.00

1.16 (1.01–1.34)

1.23 (1.03–1.46)

0.01

1.00

1.03 (0.78–1.38)

1.15 (0.84–1.58)

0.41

Deaths

173

244

119

41

36

33

Model 1

1.00

0.90 (0.74–1.10)

0.86 (0.68–1.09)

0.19

1.00

0.87 (0.55–1.36)

1.08 (0.68–1.73)

0.84

Model 2

1.00

0.85 (0.70–1.05)

0.79 (0.61–1.02)

0.05

1.00

0.86 (0.52–1.43)

0.98 (0.57–1.67)

0.89

Model 3

1.00

0.85 (0.69–1.04)

0.76 (0.59–0.98)

0.03

1.00

0.85 (0.51–1.42)

0.92 (0.53–1.59)

0.73

Deaths

253

446

211

55

61

63

Model 1

1.00

1.19 (1.02–1.39)

1.28 (1.07–1.54)

0.01

1.00

0.99 (0.69–1.43)

1.65 (1.15–2.37)

0.01

Model 2

1.00

1.17 (0.996–1.37)

1.19 (0.99–1.45)

0.05

1.00

0.86 (0.59–1.25)

1.46 (0.99–2.16)

0.09

Model 3

1.00

1.15 (0.98–1.35)

1.15 (0.95–1.40)

0.11

1.00

0.86 (0.59–1.25)

1.50 (1.003–2.25)

0.09

111
-

Hematologic cancer mortality

Non-Hodgkin lymphoma survivors
All-cause mortality

Myeloma survivors
All-cause mortality

Leukemia survivors
All-cause mortality

Acute leukemia survivors
All-cause mortality
Deaths

135

224

Model 1

1.00

1.29 (1.04–1.61)

1.51 (1.18–1.95)

0.001

-

-

Model 2

1.00

1.29 (1.03–1.60)

1.46 (1.13–1.91)

0.003

-

-

-

Model 3

1.00

1.27 (1.01–1.58)

1.39 (1.06–1.82)

0.01

-

-

-

Deaths

104

190

82

42

49

54

Model 1

1.00

1.16 (0.91–1.48)

1.08 (0.81–1.44)

0.50

1.00

0.98 (0.65–1.48)

1.71 (1.14–2.56)

0.01

Model 2

1.00

1.16 (0.91–1.49)

0.99 (0.73–1.34)

0.89

1.00

0.84 (0.54–1.29)

1.57 (1.02–2.42)

0.06

Model 3

1.00

1.13 (0.88–1.46)

0.95 (0.69–1.29)

0.88

1.00

0.86 (0.55–1.32)

1.69 (1.07–2.67)

0.04

Chronic leukemia survivors
All-cause mortality

HR = hazard ratio, CI = confidence interval, TV = television, BMI = body mass index. Model 1: adjusted for age at exposure assessment (continuous), age at cancer
diagnosis (continuous), and sex. Model 2: adjusted for all variables in Model 1 and additionally adjusted for education (less than 12 yrs, 12 yrs, vocational training or
some college education, college graduate/postgraduate, unknown), race (non-Hispanic White, non-Hispanic Black, other, unknown), smoking (never smoker, former
smoker with 20 cigarettes per day or less, former smoker with more than 20 cigarettes per day, current smoker with 20 cigarettes per day or less, current smoker with
more than 20 cigarettes per day, missing), alcohol consumption (0, >0 to 14.9, 15g/d), chemotherapy (yes, no, unknown/missing), hematologic cancer subtype (NHL,
HL, myeloma, leukemia) and stage in NHL survivors (localized/regional/in situ, systemic disease, unknown/not abstracted/missing), and physical activity. Model 3:
adjusted for all variables in Model 2 and additionally adjusted for body mass index (18.5-<25.0kg/m2, 25.0-<30.0 kg/m2, 30.0-<35.kg/m2, 35-<65 kg/m2). Data were
not evaluated for post-diagnosis physical activity due to low sample size (n = 23).
Data were not evaluated for post-diagnosis TV viewing due to low sample size (n = 21)
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Among hematologic cancer survivors who provided information on both pre- and post-diagnosis exposures, we observed a statistically significant positive association between post-diagnosis TV viewing and mortality in models that were additionally adjusted for pre-diagnosis
TV viewing (S1 Table).

Joint associations of physical activity and TV viewing
In an evaluation of joint associations of MVPA and TV viewing with risk of all-cause mortality,
we noted that the combination of regular pre-diagnosis MVPA (1 hr/wk) and low levels of
pre-diagnosis TV viewing (0 to 2 hrs/d) was related to reduced mortality risk among all hematologic cancer survivors, NHL survivors, and leukemia survivors compared to low MVPA levels
(<1 hr/wk) and a high volume of TV viewing (3 hrs/wk) (Table 4). Moreover, regular postdiagnosis MVPA was associated with reduced mortality risk at both low and high volumes of
TV viewing among all hematologic cancer survivors, NHL survivors, and leukemia survivors.

Sub-analyses
Stratified analysis indicated that post-diagnosis TV viewing was significantly related to
increased mortality among all hematologic cancer survivors aged 69 years (median) and older
Table 4. Joint associations of pre- and post-physical activity and TV viewing with all-cause mortality among survivors of hematologic malignancies.
TV viewing
Physical activity

Pre-diagnosis
All hematologic
cancer survivors

Low (<1 h/wk)

High (1 h/wk)

NHL survivors

Myeloma
survivors

Leukemia
survivors

Acute leukemia
survivors

Chronic leukemia
survivors

High
(3 to
hrs/d)

Low (0 High
to 2 hrs/ (3 to
d)
hrs/d)

Low (0 High
to 2 hrs/ (3 to
d)
hrs/d)

Low
(3 to
hrs/d)

High
(3 to
hrs/d)

Low (0 High
to 2 hrs/ (3 to
d)
hrs/d)

Low (0 High
to 2 hrs/ (3 to
d)
hrs/d)

Low (0
to 2 hrs/
d)

519

178

209

85

102

34

196

56

103

31

80

23

Multivariable1.00
adjusted HR (95%
CI)

0.91
(0.77–
1.08)

1.00

0.91
(0.71–
1.18)

1.00

1.16
(0.78–
1.74)

1.00

0.89
(0.66–
1.21)

1.00

0.61
(0.41–
0.93)

1.00

0.98
(0.61–
1.58)

Deaths

587

552

250

255

137

456

192

230

102

190

78

0.74
(0.65–
0.83)

0.87
(0.74–
1.02)

0.71
(0.59–
0.86)

0.75
(0.59–
0.95)

0.93
(0.71–
1.21)

0.85
(0.71–
1.01)

0.70
(0.57–
0.86)

0.79
(0.61–
1.01)

0.64
(0.48–
0.85)

0.77
(0.58–
1.004)

0.66
(0.47–
0.92)

42

12

-

-

1.00

0.89
(0.45–
1.75)

61

30

-

-

0.66
(0.43–
1.01)

0.62
(0.38–
1.02)

Deaths

1292

Multivariable0.83
adjusted HR (95% (0.75–
CI)
0.92)

Post-diagnosis
Low (<1 h/wk)

High (1 h/wk)

57

55

29

30

12

50

14

Multivariable1.00
adjusted HR (95%
CI)

Deaths

140

0.83
(0.61–
1.13)

1.00

0.83
(0.53–
1.31)

1.00

0.76
(0.37–
1.59)

1.00

0.85
(0.46–
1.60)

Deaths

142

115

70

39

29

74

40

0.63
(0.50–
0.81)

0.69
(0.50–
0.95)

0.62
(0.43–
0.90)

0.50
(0.29–
0.85)

0.67
(0.36–
1.24)

0.60
(0.41–
0.88)

0.57
(0.37–
0.89)

234

Multivariable0.62
adjusted HR (95% (0.5–
CI)
0.77)

HR = hazard ratio, CI = confidence interval, TV = television, BMI = body mass index. Low PA = low physical activity (<1 hr/wk), High PA = high physical activity (1
hr/wk), Low TV = low television viewing (<3 hrs/d), High TV = high television viewing (3 hrs/d). Multivariable models are adjusted for age at exposure assessment
(continuous), age at cancer diagnosis (continuous), education (less than 12 yrs, 12 yrs, vocational training or some college education, college graduate/postgraduate,
unknown), race (non-Hispanic White, non-Hispanic Black, other, unknown), smoking (never smoker, former smoker with 20 cigarettes per day or less, former smoker
with more than 20 cigarettes per day, current smoker with 20 cigarettes per day or less, current smoker with more than 20 cigarettes per day, missing), alcohol
consumption (0, >0 to 14.9, 15g/d), hematologic cancer subtype (NHL, HL, myeloma, leukemia) and stage in NHL survivors (localized/regional/in situ, systemic
disease, unknown/not abstracted/missing), and chemotherapy (yes, no, unknown/missing).
Data were not evaluated for the post-diagnosis combination of physical activity and TV viewing due to low sample size.
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at diagnosis (multivariable-adjusted HR = 1.51, 95% CI = 1.15–2.00), whereas a statistically
non-significant inverse association was detected among those aged <69 years (HR = 0.89, 95%
CI = 0.64–1.25, P-interaction = 0.03, S2 Table). Stratification by pre-diagnosis TV viewing
time indicated a stronger positive association between high versus low levels of post-diagnosis
TV viewing and mortality among those with a high amount of pre-diagnosis TV viewing time
than those with lower amounts of pre-diagnosis TV viewing time, although the p for interaction was not statistically significant (p = 0.20, S3 Table).
In supplementary analyses, we additionally adjusted for self-reported health (S4 Table and
S5 Table) and found that the MVPA and mortality relations among NHL and leukemia survivors were attenuated (S4 Table).
Excluding participants diagnosed with hematologic cancer within one year of exposure
assessment or excluding participants who answered the questionnaire in the 12 months prior
to death did not meaningfully alter the interpretation of the results on MVPA or TV viewing
and all-cause mortality among all hematologic cancer survivors (S6 Table and S7 Table). Notably, the inverse associations of post-diagnosis MVPA and all-cause mortality among all leukemia survivors and chronic leukemia survivors were attenuated after excluding individuals who
died within the first year of exposure assessment (S6 Table).

Discussion
In this large prospective cohort study, increased MVPA both before and after diagnosis was
associated with reduced risk of all-cause mortality among adult survivors of NHL, myeloma,
and leukemia. Pre-diagnosis MVPA was also related to decreased risk of hematologic cancerspecific mortality. By comparison, the association between post-diagnosis MVPA and hematologic cancer-specific mortality was not statistically significant. The results for TV viewing and
mortality risk did not show a clear pattern.
Data regarding the relationship between exercise and survival among hematologic cancer
patients are limited to two randomized controlled trials and one prospective epidemiologic
investigation [13–15]. The Healthy Exercise for Lymphoma Patients (HELP) Trial reported
that random assignment to 12 weeks of exercise had no effect on survival among 122 lymphoma patients during the 61-month follow-up period. However, secondary analyses that
broke the randomization and accounted for a potential cross-over effect of exercise among
controls showed a statistically non-significant improvement in progression-free survival
(HR = 0.69, 95% CI = 0.45–1.06) [13]. The other trial [14] found a significantly reduced
mortality risk among 103 allogeneic stem cell transplant patients with a combination of
endurance and resistance exercise (total mortality rates for exercise vs. control group:
12.0 vs. 28.3%, P = 0.03) over two years. However, those trials [13, 14] were not primarily
designed to evaluate survival outcomes and were compromised by small sample sizes and
heterogeneous patient populations. In a recent epidemiologic investigation among 238
DLBCL and 175 follicular lymphoma cases [15], a 41% risk reduction in mortality was
found among DLBCL survivors comparing high versus low levels of pre-diagnosis physical
activity.
Biologic mechanisms explaining the apparent protective effect of physical activity on mortality among hematologic cancer survivors are speculative. Physical activity may mediate
numerous pathways associated with cancer progression and the development of other chronic
diseases including energy metabolism, insulin, insulin-like growth factor-1, chronic inflammation, the immune system, and antioxidant pathways [31, 32]. We found that the pre-diagnosis
MVPA and mortality relation among myeloma survivors was no longer statistically significant
following additional control for BMI. Myeloma is more strongly related to BMI than other
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hematologic malignancies [33], stressing a potential mediator role of BMI for the MVPA and
myeloma survival relation.
It has been suggested that cancer patients who exercise regularly before diagnosis are more
likely to remain physically active post-diagnosis [34] and may be pre-disposed to biologically
less aggressive tumors [16] showing a lower rate of relapse. Physical activity may also beneficially influence the treatment process [13, 35] through improved completion rates and treatment response, and the probability of receiving second- and third-line cancer treatments.
Physical activity performed after diagnosis may reduce comorbidities [36], thereby lowering
mortality risk.
In sensitivity analyses, the inverse association between post-diagnosis MVPA and all-cause
mortality among leukemia survivors was attenuated after excluding deaths within 12 months
of the activity assessment. We recognize that sick patients may have been less physically active
after diagnosis due to symptoms and occult disease leading to reverse causation, which may
have resulted in the strong inverse association noted for post-diagnosis activity.
Our study showed mixed results regarding TV viewing and survival, which may be due to
chance, low sample size, or cancer-specific effects. We also found that the post-diagnosis TV
viewing relation became statistically significant after additional control for pre-diagnosis TV
viewing time suggesting that the relation for post-diagnosis TV viewing may be partly confounded by pre-diagnosis TV viewing. Moreover, the pre-diagnosis TV viewing and mortality
association was attenuated after including BMI in the models. Obesity may represent a plausible biologic pathway by which sedentary behavior contributes to the development of chronic
disease [37]. In animal studies, hindlimb unloading has been shown to suppress skeletal muscle lipoprotein lipase production, a key enzyme in the regulation of the glucose and lipid
metabolism [38–40]. Other potential pathways include chronic inflammation, oxidative stress,
sex hormones, and alterations in the immune system [37, 41]. A potential adverse effect may
also be partly attributable to unhealthy eating [42] and smoking behaviors [43] associated with
prolonged TV viewing.
Strengths of our study include its prospective design, adjustment for a number of important
confounding variables, and availability of information on physical activity and TV viewing
from two questionnaires which allowed conducting pre- and post-diagnosis analyses. Nevertheless, several limitations must be considered in terms of interpreting our findings. Our
results by hematologic cancer subtype may have been underpowered by virtue of the low sample sizes in those subtype-specific analyses. As mentioned above, we cannot exclude the possibility that reverse causation due to occult disease at the time of exposure assessment may have
affected our results. Moreover, we cannot rule out the potential for measurement error resulting from self-reported assessments of physical activity and TV viewing. Although we carefully
controlled for a wide range of potential confounding variables, residual confounding through
covariates measured with error is possible.
Our findings suggest that it is advisable to counsel hematologic cancer survivors to engage
in regular physical activity to improve survival after diagnosis. The physical activity guidelines
set forth by the U.S. Department of Health and Human Services and the American Cancer
Society [44] advocate individuals affected by cancer to comply with the physical activity recommendations for the general adult population and to engage in at least 150 minutes of moderate activity per week, with the understanding that exercise prescription may need to be
adjusted to their abilities and conditions.
In conclusion, our findings suggest improved survival attributable to high MVPA levels
before and after diagnosis among survivors of hematologic malignancies. Our study did not
show a clear pattern for TV viewing. In future studies, objective quantification of physical
activity is required to determine the proper volume and duration of physical activity needed to

PLOS ONE | https://doi.org/10.1371/journal.pone.0192078 January 31, 2018

10 / 14

Physical activity, television viewing and hematologic cancer survival

improve cancer survival. Future work is also needed to clarify whether the relations differ
across histologic subtypes taking into account clinical parameters such as cancer stage, treatment, and time since diagnosis. Finally, whether TV viewing increases risk of mortality among
hematologic cancer survivors requires further evaluation.
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